BOAN BIOTECH (06955) has announced that on April 28, 2026, the board of directors resolved to propose the adoption of a restricted share unit incentive scheme for the company's H-shares. The incentive plan is designed to further improve the company's long-term talent incentive structure, motivate core employees to contribute to the company's growth, and better align the interests of shareholders, the company, and its management team. This initiative aims to support the company's sustained and stable long-term development.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments